(Date:1/8/2009)...TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg... of Canada,s leading providers of health services,... voted in favour of the previously announced plan ... Group Inc. ("AIM") at a special meeting of MedEme... of 90% of the votes cast at the meeting were in f...
(Date:1/8/2009)...ALEXANDRIA, Va., Jan. 8 ...rganization along with several national leadership...ing the principles of hospice care and protection ... standing together in sharing this unified message...on of Hospice and Palliative Medicine, Hospice and...
(Date:1/8/2009)...California Assembly Member Tom Torlakson Introduce...ire-USNewswire/ -- Today, Lung Cancer Alliance-C...ber Tom Torlakson (D-11th District) for his contin...g funding for lung cancer research. For the third...g cancer research is being considered in the Calif...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2...to ten, identified colours and even dabbled with F...an IQ test that her soaring brainpower was establi...e youngest female celebrated member of Mensa. The ...chief executive and a carpenter, Georgia has been ...
...nteers are participating in a six-day long rally h...drug trafficking. Adorning characteristic yellow...e streets of Imphal to send across the message on ...ugs. Over 350 cyclists and 200 volunteers are part...
...merican Journal of Gastroenterology, indicates tha...nd 304 patients has confirmed that polyethylene (...chronic constipation, even elderly patients can us... Until recently, few data were available regardin...
...bly heavier than others. Researchers at the US Na...se Control and Prevention and the Cincinnati Chil...ormones could be contributing to such a phenomenon...children with autism have very rapid head growth i...
Other Medicine News:Health News:Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius 2Health News:Autism Could Be Related to Higher Level of Growth Hormones 2(Date:1/6/2009)...Proves significance of AHCC for maintaining a heal...RNewswire/ -- A recently published study in Nutri...t Kansai Medical University in Osaka, Japan has sh...enhances immune function by increasing the number ...e immune system responsible for presenting foreign...
(Date:1/6/2009)...ROCKVILLE, Md., Jan. 6 ... company focused on diseases of epidemic potential...ate for the treatment of tuberculosis (TB), was th...arded clinical program contract to Dynport Vaccine...ract, awarded by the National Institute of Allergy...
(Date:1/6/2009)... PARIS, France, January 6 /PRNewswire-FirstCall...Extend the Collaboration Until,December 2011 ,... to Include Antibody,Discovery in Ophthalmology ,... ExonHit if Allergan,Sublicenses to a Third Party...) today announced a reinforcement,of its existing...
(Date:1/5/2009)... SAN JOSE, Calif., Jan. 5 Women...progesterone medication to help support early,pre...forms of this medication,can be painful for patie...h,can be administered by subcutaneous injection o...ith better patient tolerance. , With patien...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Strikeithealthyfamily com Provides Parents With Sense of Relief 31548 1Strikeithealthyfamily com Provides Parents With Sense of Relief 31548 2Baxa Features Rapid Fill 28TM 29 Colored Labels PACT 28TM 29 Products Exacta Mix 28TM 29 2400 Compounders and Abacus 28TM 29 Software at the ASHP Mi 9547 1Baxa Features Rapid Fill 28TM 29 Colored Labels PACT 28TM 29 Products Exacta Mix 28TM 29 2400 Compounders and Abacus 28TM 29 Software at the ASHP Mi 9547 2Baxa Features Rapid Fill 28TM 29 Colored Labels PACT 28TM 29 Products Exacta Mix 28TM 29 2400 Compounders and Abacus 28TM 29 Software at the ASHP Mi 9547 3Laws Governing Indoor Tanning by Teens Dont Work 31542 1Laws Governing Indoor Tanning by Teens Dont Work 31542 2Laws Governing Indoor Tanning by Teens Dont Work 31542 3Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 31537 1Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 31537 2Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 31537 3Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 31537 4Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 31537 5...ELS, Belgium and KOS, Greece, June 29, 2007 /PRNew... updated data for,previously treated patients on R...one shows median survival of 35 months, nearly,thr...mized,controlled Phase III trials that enrolled mo...s worldwide. These updated results,were presented ...
... Presentation of efficacy trends from ongoing phas... ESMO for presentation in,press conference , MARTI...ny,MediGene AG (Frankfurt, Prime Standard: MDG) an...al trial of MediGene,s cancer killing,virus will b...pean,Society for Medical Oncology. Out of more tha...
Other Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut
An easy to use uncomplicated ophthalmoscope.
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame.
Halberg Trial Clips have become a required addition to every refractive stand., ,These useful and inexpensive clips may be fitted over your patient's spectacle frame. Each cell has space for thre
Medicine Products: